Recall Z-0987-2013

Abbott Laboratories, Inc · initiated December 18, 2012

Class II Terminated

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

ARCHITECT HBsAg Qualitative Assay, List Number 4P53 and ARCHITECT HBsAg Qualitative Confirmatory Assay, List Number 4P54 The ARCHITECT HBsAg Qualitative assay is a chemiluminescent microparticle immunoassay (CMIA) for the qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric serum and plasma and neonate serum.

Codes / lots: All shipped out to this date

Reason for recall

Abbott has identified that assay files for the ARCHITECT HBsAg Qualitative and HBsAg Qualitative Confirmatory assays (LNs 4P53 and 4P54) on the ARCHITECT i1000SR System were mistakenly made available on abbottdiagnostics.com in October 2012. Additionally, some i1000SR customers received notification through AbbottLink in November 2012 that assay files for LNs 4P53 and 4P54 were available. The AR

FDA-determined cause: No Marketing Application

Action taken

The firm decided to correct the issue and and sent out Urgent Field Safety Notices to their customers dated 10/18/2012.

Details

Recall number
Z-0987-2013
Initiated
December 18, 2012
Posted by FDA
March 25, 2013
Terminated
July 31, 2013
Product code
LOM – Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Quantity
12
Distribution
Nationwide Distribution including AZ, CA, FL, GA, HI, LA, MA, MD, MO, NJ, NY, PA, RI, TN, TX, UT, and WA.
Recalling firm
Abbott Laboratories, Inc, Irving, TX

Official FDA recall record